The role of gene therapy in haemophilia
- 1 January 1995
- journal article
- Published by Wiley in Haemophilia
- Vol. 1 (S1) , 40-43
- https://doi.org/10.1111/j.1365-2516.1995.tb00109.x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Adenovirus mediated expression of therapeutic plasma levels of human factor IX in miceNature Genetics, 1993
- In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient DogsScience, 1993
- Toward Gene Therapy for Hemophilia A: Long-Term Persistence of Factor VIII-Secreting Fibroblasts after Transplantation into Immunodeficient MiceHuman Gene Therapy, 1993
- Towards gene therapy for haemophilia B using primary human keratinocytesNature Genetics, 1993
- Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo.Proceedings of the National Academy of Sciences, 1992
- Gene therapy for human inherited disorders: techniques and statusCritical Reviews in Oncology/Hematology, 1992
- Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B.Proceedings of the National Academy of Sciences, 1991
- Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs.Proceedings of the National Academy of Sciences, 1990
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990
- An alternative approach to somatic cell gene therapy.Proceedings of the National Academy of Sciences, 1988